X

Trial Profile

A Multicenter,Open Label Crossover Study to Assess the Pharmacokinetics and Safety of Diazepam Buccal Soluble Film (DBSF) in Pediatric Subjects With Epilepsy

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 16 Apr 2024

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Diazepam (Primary)
Indications Epilepsy; Seizures
Focus Pharmacokinetics
Sponsors Aquestive Therapeutics

Most Recent Events

12 Apr 2024 According to an Aquestive Therapeutics media release, the company to present data from this trial at the 76th Annual Meeting of the American Academy of Neurology (AAN) in Denver from April 13 to 18.
25 May 2021 Status changed from active, no longer recruiting to completed.
24 Jun 2020 Planned End Date changed from 1 May 2020 to 1 Jun 2020.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com